| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 10/25/2007 | CA2650998A1 Liquid composition for external application and preparation for external application for treatment of skin ulcer |
| 10/25/2007 | CA2649735A1 Activating agent for peroxisome proliferator activated receptor .delta. |
| 10/25/2007 | CA2648950A1 Composition including at least one aqueous phase and at least one fatty phase including ivermectin |
| 10/24/2007 | EP1847550A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 10/24/2007 | EP1847541A1 Fused pyrimidine derivative and uses thereof |
| 10/24/2007 | EP1847270A1 Use of amygdalin analogues for the treatment of psoriasis |
| 10/24/2007 | EP1847267A2 Method of photodynamic diagnosis for vascular diseases |
| 10/24/2007 | EP1847182A2 Foodstuffs or dietary supplements containing flavonoid derivates |
| 10/24/2007 | EP1846391A2 Raf inhibitor compounds and methods |
| 10/24/2007 | EP1846370A2 2-METHYLENE-19-NOR-1&agr;-HYDROXY-17-ENE-HOMOPREGNACALCIFEROL AND ITS USES |
| 10/24/2007 | EP1846369A2 2alpha-methyl-19-nor-(20s)-1alpha-hydroxy-bishomopregnacalciferol and its uses |
| 10/24/2007 | EP1846084A1 Device and method for treatment of wounds with nitric oxide |
| 10/24/2007 | EP1846010A1 External skin agent comprising modified clay for preventing inflammation |
| 10/24/2007 | EP1845965A1 Adapalene for the long-term treatment of acne vulgaris |
| 10/24/2007 | EP1845785A1 Herbal composition for tinea infection |
| 10/24/2007 | EP1755630B1 Pharmaceutical compositions from beard lichen (usnea barbata) and st. john's wort (hypericum perforatum) and their use |
| 10/24/2007 | EP1661565B1 Composition comprising l-proline for the treatment of vitiligo |
| 10/24/2007 | EP1218348B1 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 10/24/2007 | EP1178983B1 Indole-type derivatives as inhibitors of p38 kinase |
| 10/24/2007 | CN200963353Y 瘢痕膏药贴 Scar plaster paste |
| 10/24/2007 | CN101060828A Surfactant composition |
| 10/24/2007 | CN101057963A Traditional Chinese medicine for treating scald and its preparation method |
| 10/24/2007 | CN101057962A Medicine for treating burn and scald |
| 10/24/2007 | CN101057956A Traditional Chinese medicine preparation for treating ichthyosis |
| 10/24/2007 | CN101057955A Traditional Chinese medicine preparation for curing acute eczema |
| 10/24/2007 | CN101057944A Medicinal composite for treating bromhidrosis and its producing method |
| 10/24/2007 | CN101057942A External applied medicine ointment for treating diabetes foot and its preparing method |
| 10/24/2007 | CN101057937A Traditional Chinese medicine for curing white hairs |
| 10/24/2007 | CN101057928A Traditional Chinese medicine for treating ichthyosis |
| 10/24/2007 | CN101057923A Traditional Chinese medicine preparation for treating burn in no scar |
| 10/24/2007 | CN101057922A Traditional Chinese medicine preparation for treating vitiligo |
| 10/24/2007 | CN101057905A Microwave extraction method for cordate houttuynia total flavones |
| 10/24/2007 | CN101057904A Medicine powder for treating skin trauma and empyrosis in no scar |
| 10/24/2007 | CN101057903A Traditional Chinese medicine preparation for curing acute eczema |
| 10/24/2007 | CN101057897A Medicine for treating scald and burn and its preparation method |
| 10/24/2007 | CN101057896A Traditional Chinese medicinal embrocation for treating psoriasis |
| 10/24/2007 | CN101057878A Pomegranate rind extraction and its preparation method |
| 10/24/2007 | CN101057870A Liquid medicine for treating burns and its preparing method |
| 10/24/2007 | CN101057825A Compound all-trans retinoic acid cream and its preparation method and application |
| 10/24/2007 | CN101057670A Health products for removing chloasma |
| 10/24/2007 | CN101057669A Health products for removing chloasma |
| 10/24/2007 | CN100344677C 凝胶组合物 Gel compositions |
| 10/24/2007 | CN100344648C Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 10/24/2007 | CN100344646C Oligonucleotide-containing pharmacological compositions and their use |
| 10/24/2007 | CN100344638C Aminophosphonic acid derivatives, addition salts thereof and S1P receptor modulators |
| 10/24/2007 | CN100344616C Compounds for the treatment of metabolic disorders |
| 10/24/2007 | CN100344324C Cream of liposome of interferon |
| 10/24/2007 | CN100344311C Chinese medicine composition for treating nettle-rash and skin itch and its preparing method |
| 10/24/2007 | CN100344310C Medicine for treating tinea containing biological alkaline salt and preparation thereof |
| 10/24/2007 | CN100344301C Orally medicine for treating vitiligo and production method thereof |
| 10/24/2007 | CN100344297C Photocatalyst anti-inflammation antibacterial medicinal ointment and its preparation method |
| 10/23/2007 | US7285683 Bicyclic and tricyclic cannabinoids |
| 10/23/2007 | US7285680 β-alanine derivatives and the use thereof |
| 10/23/2007 | US7285635 Reducing the antigenicity of a proteinaceous compound while maintaining the compound's biological activity |
| 10/23/2007 | US7285568 Substituted p-(2-alkoxy-2-acylethyl)biphenyl compounds, e.g., 1-[4'-(2-ethoxy-3-morpholin-4-yl-3-oxopropyl)biphenyl-3-yl]-3-heptyl-1-methylurea; useful in human or veterinary medicine: dermatology, cardiovascular diseases, immune diseases, and diseases associated with lipid metabolism |
| 10/23/2007 | US7285560 E.g., N-[(S)-2-diphenylamino-1-(5-oxo-4,5-dihydro[1,3,4]oxadizol-2-yl)ethyl]-2-(2-methylaminopyrimidin-4-yl)-1H-indole-5-carboxamide; used for treating rheumatoid arthritis, osteoarthritis, asthma, cardiac infarction, Alzheimer's diseases, cancer diseases or atherosclerosis |
| 10/23/2007 | CA2380052C Nicotine receptor agonists in stem cell and progenitor cell recruitment |
| 10/18/2007 | WO2007118198A2 2-METHYLENE-1α,25-DIHYDROXY-19,21-DINORVITAMIN D3 ANALOGS AND USES THEREOF |
| 10/18/2007 | WO2007116731A1 Composition containing reduced coenzyme a |
| 10/18/2007 | WO2007116147A1 Healing composition |
| 10/18/2007 | WO2007116052A1 Oral composition comprising dha and genistein for enhancing skin properties |
| 10/18/2007 | WO2007116029A2 Combination comprising a) a pyrimidylaminobenzamide compound, and b) a thr315lle kinase inhibitor |
| 10/18/2007 | WO2007116027A1 Oral composition comprising a polyunsaturated fatty acid and salicylic acid for obtaining an antiinflammatory effect in skin |
| 10/18/2007 | WO2007116013A1 Use of a galactose-derived c-glycoside compound as an agent for activating and regulating cutaneous immunity |
| 10/18/2007 | WO2007116012A1 Use of a d- and l-fucose-derived c-glycoside compound as an agent for activating and regulating cutaneous immunity |
| 10/18/2007 | WO2007115934A1 Oral composition with an antiageing effect on the skin |
| 10/18/2007 | WO2007115822A1 Thienopyrimidines having mnkl /mnk2 inhibiting activity for pharmaceutical compositions |
| 10/18/2007 | WO2007115820A1 Chromen-2-one derivatives |
| 10/18/2007 | WO2007115473A1 Pyrrole derivatives inhibitors, their curative uses |
| 10/18/2007 | WO2007092721A3 Vitamin d analog: rak, methods and uses thereof |
| 10/18/2007 | WO2007092720A3 Vitamin d analog: nel, methods and uses thereof |
| 10/18/2007 | WO2007089929A3 Osmium compounds for treatment of psoriasis |
| 10/18/2007 | WO2007076473A3 Substituted pyrimidinyloxy ureas useful as inhibitors of protein kinases |
| 10/18/2007 | WO2007059836A3 Compositions containing proteins for the transfer/recycling of structurally modified lipids, and the applications thereof |
| 10/18/2007 | US20070244172 Compounds for the treatment of metabolic disorders |
| 10/18/2007 | US20070244171 Compounds for the treatment of metabolic disorders |
| 10/18/2007 | US20070244141 Compounds for the treatment of metabolic disorders |
| 10/18/2007 | US20070244139 Indole Derivatives or Benzimidazole Derivatives for Modulating IkB Kinase |
| 10/18/2007 | US20070244133 Thienopyrimidines and Thiazolopyrimidines for Use in Medicine |
| 10/18/2007 | US20070244127 Stable Dosage Form of Phenylalanine Derivatives |
| 10/18/2007 | US20070244123 Heterocycle-carboxamide derivatives as raf kinase inhibitors |
| 10/18/2007 | US20070243270 prevent skin damage caused by ultraviolet radiation by administering a oral dosage of alpha-lipoic acid, n-acetyl cysteine, green tea extract, turmeric extract, and quercetin, and applying s topical dosage form comprising plant extracts of berry, bitter orange peel, lemon, cucumber and herbs |
| 10/18/2007 | US20070243226 Growth factor complex |
| 10/18/2007 | US20070243185 Suitable for long-term storage of polypeptides containing an Fc domain of an immunoglobulin; containing polypeptide with an aggregation inhibitor selected from the group consisting of L-arginine and L-cysteine. |
| 10/18/2007 | US20070243163 Respiratory tract delivery of interferon-tau |
| 10/18/2007 | US20070243144 External Preparation |
| 10/18/2007 | DE102007016665A1 Kosmetische, pharmazeutische und/oder dermatologische Zusammensetzungen enthaltend langkettige Fettalkohole und/oder deren Derivate Cosmetic, pharmaceutical and / or dermatological compositions comprising long chain fatty alcohols and / or derivatives thereof |
| 10/18/2007 | DE102006011314A1 Kosmetische Zubereitungen mit einem Zusatz aus der Baobab-Pflanze Cosmetic preparations containing additive from the baobab plant |
| 10/18/2007 | CA2651898A1 Thienopyrimidines having mnk1/mnk2 inhibiting activity for pharmaceutical compositions |
| 10/18/2007 | CA2648324A1 2-methylene-1.alpha.,25-dihydroxy-19,21-dinorvitamin d3 analogs and uses thereof |
| 10/18/2007 | CA2647803A1 Combination comprising a) a pyrimidylaminobenzamide compound, and b) a thr315lle kinase inhibitor |
| 10/18/2007 | CA2644951A1 Chromen-2-one derivatives |
| 10/17/2007 | EP1845106A1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 10/17/2007 | EP1844786A1 Extracts of Curcuma longa and their cosmetic and dermatological uses |
| 10/17/2007 | EP1844784A1 A pharmaceutical composition for the treatment of pathologies caused by the general response of the immune system |
| 10/17/2007 | EP1844778A1 Agent for prevention/therapy of disease caused by keratinocyte growth |
| 10/17/2007 | EP1844774A2 A pharmaceutical composition for angiotensin II-mediated diseases |
| 10/17/2007 | EP1844146A2 Cosmetic or pharmaceutical preparations containing nucleic acids having sequences suited for forming stem-loop secondary structures |
| 10/17/2007 | EP1844069A1 Molecules and chimeric molecules thereof |
| 10/17/2007 | EP1843789A2 Compositions and methods for treating fibrotic disorders |